Zhejiang Jiangbei Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATORVASTATIN CALCIUM, with a corresponding US DMF Number 31764.
Remarkably, this DMF maintains an Active status since its submission on April 18, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 15, 2017, and payment made on October 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II